Solid Biosciences Inc.
SLDB
$3.38
$0.082.42%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 16.18% | -5.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.40% | 26.61% | |||
| Operating Income | -13.40% | -26.61% | |||
| Income Before Tax | -30.17% | -30.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.17% | -30.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.17% | -30.52% | |||
| EBIT | -13.40% | -26.61% | |||
| EBITDA | -13.32% | -30.97% | |||
| EPS Basic | -26.32% | -28.91% | |||
| Normalized Basic EPS | -26.32% | -28.92% | |||
| EPS Diluted | -26.32% | -28.91% | |||
| Normalized Diluted EPS | -26.32% | -28.92% | |||
| Average Basic Shares Outstanding | 3.05% | 1.24% | |||
| Average Diluted Shares Outstanding | 3.05% | 1.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||